Production of extracellular domains of human desmoglein type 3 in CHO cells and the study of their specificity with serum from pemphigus vulgaris patients

被引：0
|
作者：
Ilina, E. [1 ]
Aliev, T. [1 ]
Balabashin, D. [2 ]
Dolgikh, D. [1 ,2 ]
Karamova, A. [3 ]
Deryabin, D. [3 ]
Kubanov, A. [3 ]
Gabibov, A. [2 ]
Kirpichnikov, M. [1 ,2 ]
机构：
[1] Lomonosov MSU, Moscow, Russia
[2] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
[3] State Res Ctr Dermatovenerol & Cosmetol, Moscow, Russia
来源：
FEBS OPEN BIO | 2021年 / 11卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-08.3-30
引用
收藏
页码：449 / 449
页数：1
相关论文
共 50 条
  • [21] The N-terminal fraction of desmoglein 3 encompassing its immunodominant domain is present in human serum: Implications for pemphigus vulgaris autoimmunity
    Lanza, A.
    Femiano, F.
    De Rosa, A.
    Cammarota, M.
    Lanza, M.
    Cirillo, N.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2006, 19 (02) : 399 - 407
  • [22] T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris
    Hacker-foegen, MK
    Fairley, JA
    Lin, MS
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (06) : 1365 - 1372
  • [23] Type 17 T follicular helper cells promote desmoglein 1/3-specific autoantibody production in pemphigus
    Holstein, J.
    Solimani, F.
    Baum, C.
    Meier, K.
    Robert, P.
    Didona, D.
    Tekath, T.
    Dugas, M.
    Casadei, N.
    Matthes, J.
    Schaefer, I.
    Polakova, A.
    Hudemann, C.
    Stach, R.
    Yazdi, A.
    Eming, R.
    Hertl, M.
    Pfuetzner, W.
    Kamran, G.
    Moebs, C.
    [J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E65 - E65
  • [24] Intravenous immunoglobulin regulates anti-desmoglein 3 autoantibody production in B220-antibody-producing cells in mice with pemphigus vulgaris
    Kase, Y.
    Yamagami, J.
    Wada, N.
    Takahashi, H.
    Koyasu, S.
    Amagai, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S1 - S1
  • [25] Pathogenic autoantibodies from mucosal pemphigus vulgaris recognize human specific desmoglein 3 epitopes within the EC1 domain
    McCray, S. K.
    Prisayanh, P.
    Temple, B.
    Diaz, L. A.
    Culton, D. A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S8 - S8
  • [26] Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris (vol 172, pg 6468, 2004)
    Veldman, C.
    Hoehne, A.
    Dieckmann, D.
    Schuler, G.
    Hertl, M.
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 189 (07): : 3778 - 3778
  • [27] Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratmocytes
    Cirlllo, N
    Femiano, F
    Gombos, F
    Lanza, A
    [J]. FEBS LETTERS, 2006, 580 (13) : 3276 - 3281
  • [28] Anti-desmoglein-3 auto antibodies obtained from pemphigus vulgaris patients in clinical remission may induce apoptosis in HaCaT keratinocytes
    Narbutt, I.
    Lesiak, A.
    Sysa-Jedrzejowska, A.
    Kovalewki, C.
    Wozniak, K.
    Torzecka, J. D.
    Boncela, J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S22 - S22
  • [29] Intravenous Ig Regulates Anti-Desmoglein 3 IgG Production in B220e Antibody-Producing Cells in Mice with Pemphigus Vulgaris
    Kase, Yuko
    Takahashi, Hayato
    Ito, Hiromi
    Kamata, Aki
    Amagai, Masayuki
    Yamagami, Jun
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (07) : 1786 - +
  • [30] Recombinant Fragment of the Extracellular Domain of Human Desmoglein 3 Fused with the Fc-Fragment of Human IgG1 Selectively Adsorbs Autoreactive Antibodies from the Sera of Pemphigus Patients
    Larina, E. N.
    Karasev, V. S.
    Shpilevaya, M., V
    Aliev, T. K.
    Bochkova, O. P.
    Karamova, A. E.
    Balabashin, D. S.
    Deryabin, D. G.
    Bobik, T., V
    Smirnov, I., V
    Kubanov, A. A.
    Staroverov, S. M.
    Gabibov, A. G.
    Kirpichnikov, M. P.
    [J]. DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2021, 498 (01) : 180 - 183
12345